Resultados de procura - Quan Man
- Mostrando 1 - 3 Resultados de 3
-
1
Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ductal adenocarcinoma por Yuexiang Liang, Guannan Sheng, Yu Guo, Yiping Zou, Hanhan Guo, Zhifei Li, Shaofei Chang, Quan Man, Song Gao, Jihui Hao
Publicado 2024Artigo -
2
First‐In‐Human, First‐In‐Class, Phase I Trial of the Fucosylation Inhibitor SGN‐2FF in Patients with Advanced Solid Tumors por Do, Khanh T., Chow, Laura Quan Man, Reckamp, Karen, Sanborn, Rachel E., Burris, Howard, Robert, Francisco, Camidge, D. Ross, Steuer, Conor E., Strickler, John H., Weise, Amy, Specht, Jennifer M., Gutierrez, Martin, Haughney, Peter, Hengel, Shawna, Derleth, Christina Louise, Yap, Timothy A.
Publicado 2021Text -
3
Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis por Tianxing Zhou, Yongjie Xie, Xupeng Hou, Weiwei Bai, Xueyang Li, Ziyun Liu, Quan Man, Jingyan Sun, Danqi Fu, Jingrui Yan, Zhaoyu Zhang, Yifei Wang, Hongwei Wang, Wenna Jiang, Song Gao, Tiansuo Zhao, Antao Chang, Xiuchao Wang, Hongxia Sun, Xiufeng Zhang, Shengyu Yang, Chongbiao Huang, Jihui Hao, Jing Liu
Publicado 2023Artigo
Ferramentas de procura:
Materias Relacionadas
Biology
Cancer
Internal medicine
Medicine
Adenocarcinoma
Biochemistry
Blood pressure
Cancer research
Clinical significance
Ecology
Gemcitabine
Gene
Grading (engineering)
Immunohistochemistry
Irbesartan
Ki-67
Malignancy
Oncology
Paleontology
Pancreatic cancer
Pancreatic ductal adenocarcinoma
Pathology
Pharmacology
Stage (stratigraphy)
Survivin
Transcription factor
YAP1